YCBD cbdMD, Inc.

NYSE Perfumes, Cosmetics & Other Toilet Preparations NC CIK: 0001644903
AI RATING
SELL
75% Confidence

Investment Thesis

cbdMD faces significant operational headwinds with flat revenue growth, persistent operating losses, and negative free cash flow of -$977.3K despite a strong 59.8% gross margin. While improving losses and a pristine balance sheet with zero debt provide short-term stability, the company is burning cash operationally with limited runway, suggesting structural challenges in the CBD market that require fundamental strategic improvement.

Strengths

  • + Exceptional gross margin of 59.8% demonstrates strong product pricing power and operational efficiency at the production level
  • + Fortress balance sheet with zero long-term debt and $3.4M cash against minimal $2.8M liabilities provides financial flexibility
  • + Improving loss trajectory with 53.4% YoY improvement in net income and 92.4% improvement in EPS suggests management is taking corrective actions

Risks

  • ! Flat revenue of $5.0M with 0% YoY growth indicates inability to capture market share or grow in CBD sector; potential market saturation or demand weakness
  • ! Negative operating cash flow of -$812.5K means company is burning cash from core operations; at current run rate approximately 4-5 quarters of cash runway remains
  • ! Persistent unprofitability at operating level (-5.7% margin) and net level (-5.6% margin) despite high gross margins suggests cost structure and administrative burden are unsustainable; negative ROE and ROA

Key Metrics to Watch

Financial Metrics

Revenue
5.0M
Net Income
-283.1K
EPS (Diluted)
$-1.09
Free Cash Flow
-977.3K
Total Assets
11.8M
Cash
3.4M

Profitability Ratios

Gross Margin 59.8%
Operating Margin -5.7%
Net Margin -5.6%
ROE -3.1%
ROA -2.4%
FCF Margin -19.5%

Balance Sheet & Liquidity

Current Ratio
2.94x
Quick Ratio
1.81x
Debt/Equity
0.00x
Debt/Assets
23.5%
Interest Coverage
N/A
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-19T17:33:22.882279 | Data as of: 2025-12-31 | Powered by Claude AI